Redmile Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-11,320
| Closed | -$68K | – | 81 |
|
|
2019
Q1 | $68K | Hold |
11,320
| – | – | ﹤0.01% | 81 |
|
|
2018
Q4 | $84K | Hold |
11,320
| – | – | ﹤0.01% | 75 |
|
|
2018
Q3 | $164K | Sell |
11,320
-95,500
| -89% | -$1.38M | 0.01% | 81 |
|
|
2018
Q2 | $2.13M | Hold |
106,820
| – | – | 0.07% | 65 |
|
|
2018
Q1 | $1.87M | Sell |
106,820
-200
| -0.2% | -$3.5K | 0.07% | 57 |
|
|
2017
Q4 | $2.64M | Buy |
107,020
+6,060
| +6% | +$149K | 0.11% | 60 |
|
|
2017
Q3 | $2.61M | Buy |
100,960
+6,400
| +7% | +$165K | 0.13% | 56 |
|
|
2017
Q2 | $2.56M | Buy |
94,560
+3,860
| +4% | +$105K | 0.16% | 52 |
|
|
2017
Q1 | $2.71M | Sell |
90,700
-3,500
| -4% | -$104K | 0.18% | 54 |
|
|
2016
Q4 | $2.56M | Buy |
+94,200
| New | +$2.56M | 0.22% | 44 |
|